BioCryst Pharmaceuticals, Inc.
(NASDAQ : BCRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.18%194.391.3%$535.26m
GILDGilead Sciences, Inc.
-0.23%66.020.9%$359.21m
ALXNAlexion Pharmaceuticals, Inc.
-3.95%103.572.0%$312.68m
ILMNIllumina, Inc.
0.97%301.163.5%$306.17m
BIIBBiogen Inc.
-1.68%234.681.3%$294.65m
CELGCelgene Corporation
0.05%98.651.3%$288.51m
AAgilent Technologies, Inc.
0.56%76.831.6%$174.32m
SRPTSarepta Therapeutics, Inc.
-2.57%82.7014.6%$174.27m
VRTXVertex Pharmaceuticals Incorporated
-0.41%175.281.9%$173.83m
REGNRegeneron Pharmaceuticals, Inc.
-1.86%282.752.6%$169.38m
EXASExact Sciences Corporation
-1.62%105.1424.1%$133.00m
ACADACADIA Pharmaceuticals Inc.
-3.76%41.0013.9%$110.65m
INCYIncyte Corporation
-1.12%78.222.5%$84.76m
BMRNBioMarin Pharmaceutical Inc.
0.00%75.004.3%$71.23m
ALDRAlder Biopharmaceuticals, Inc.
0.67%18.8310.2%$64.38m

Company Profile

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.